Last reviewed · How we verify

NCT03828695

Uterocervical Angle in Idiopathic Polyhydramnios

Completed NA Last updated 23 July 2019
What this trial tests

NA trial testing uterocervical angle in Preterm Labor in 60 participants. Completed in 30 June 2019.

Timeline
1 January 2019
Primary endpoint
30 June 2019
30 June 2019

Quick facts

Lead sponsorNefise Nazlı YENIGUL
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment60
Start date1 January 2019
Primary completion30 June 2019
Estimated completion30 June 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Nefise Nazlı YENIGUL

Who can join

Adults 18 to 45, female only, with Preterm Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the performance of uterocervical angle (UCA) in the prediction of preterm labor in isolated polyhydramnios

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of uterocervical angle

Trials testing the same drug.

Other recruiting trials for Preterm Labor

Currently open trials in the same condition.

Other Nefise Nazlı YENIGUL trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03828695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing